The Landmark at Eastview property in Greenburgh has received unanimous rezoning approval from the town board, allowing developers to move into the next phase for what will become a planned economic development district.
By rezoning the land from residential and mixed-use business to a planned economic development district, the developer will have more freedom with the design of the property.
Landmark property owner Eastview Holdings LLC, a subsidiary of Pennsylvania-based LCOR Inc., can now begin making specific proposals for the future of the 100-acre land parcel.
The Business Journal recently reported there are plans to expand the growing biotech sector in the immediate area with more office and lab space, and also complement those businesses with a hotel and retail space.
The Landmark property, off Old Saw Mill River Road and west of Route 9A, is already home to Progenics Pharmaceuticals Inc. and Regeneron Pharmaceuticals Inc.
Garrett Duquesne, Greenburgh”™s development commissioner, anticipates the new construction will make way for a 125,000-square-foot hotel, about 175,000 square feet of retail and roughly 800,000 square feet for biomedical office development.
